Events8th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2022-13479 (registering DOI)
This submission belongs to the session S3. General of the event 8th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2022
Academic Editor
author-avatarMaria Emília Sousa
Citation
Marco Agostini, Donata Favretto, Andrea Duranti, Characterization of URB series synthetic cannabinoids by HRMS and HPLC–MS/MS, in Proceedings of 8th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2022, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2022-13479
Share
Email
Facebook
Twitter
LinkedIn

Characterization of URB series synthetic cannabinoids by HRMS and HPLC–MS/MS

image
1. Laboratory of Toxicology A.S.U.R. AV1, Via Lombroso 15, Pesaro, 61122, Italy
2. Legal Medicine and Toxicology, Via Falloppio 50, University Hospital of Padova, Padova, 35121, Italy
3. Department of Biomolecular Sciences, Piazza del Rinascimento 6, University of Urbino Carlo Bo, Urbino (PU), 61029, Italy
Abstract

A large number of synthetic cannabinoids are included in new psychoactive substances (NPS) and constitute an open research area in analytical pharmaceutical and toxicology, when methods are needed to unambiguously identify these substances and their metabolites in biological fluids. A full molecular characterization of five synthetic cannabinoid molecules of the URB series was achieved by high resolution mass spectrometry (HRMS) in positive ion electrospray ionization and collisional experiments on the protonated parent ions obtaining characteristic fragmentation patterns. Ultra–high performance liquid chromatography (UHPLC–MS/MS) has also been used, which can help develop methods for screening and confirming synthetic cannabinoids in biological fluids.

Keywords
NPS
synthetic cannabinoids
URB compounds
HRMS
UHPLC–MS/MS
toxicology
Poster
8th-ECMC_Poster_Agostini.pdf
Synthesis and Antifungal Activity of Thioxanthone Derivatives
Identification of new anti-SARS COV2 agents through virtual screening of phytoconstituents extracted from Moroccan plants